Chris LeMasters
Overview
Chris LeMasters received an average of $2M in total compensation, including $290K in salary, at Mirati Therapeutics from 2016 to 2019.
2019Mirati TherapeuticsFormer Executive Vice President and Chief Business Officer
2018Mirati TherapeuticsExecutive Vice President and Chief Business Officer
2017Mirati TherapeuticsExecutive Vice President and Chief Business Officer
2016Mirati TherapeuticsExecutive Vice President and Chief Business Officer
Source: SEC filings on April 17, 2020 and April 19, 2019.
Related executives
We found five more executives who work or worked at Mirati Therapeutics.
Charles Baum
Mirati Therapeutics
Chief Executive Officer
James Christensen
Mirati Therapeutics
Chief Scientific Officer
Isan Chen
Mirati Therapeutics
Executive Vice President and Chief Medical and Development Officer
Jamie Donadio
Mirati Therapeutics
Chief Financial Officer
Mark Gergen
Mirati Therapeutics